Covalis Capital’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,999
Closed -$81K 128
2021
Q3
$81K Hold
19,999
0.02% 110
2021
Q2
$91K Buy
+19,999
New +$22.5K 0.03% 114

Other funds holding WPCB.WS

Covalis Capital's WPCB.WS Position: Q4 2021 in Review

Covalis Capital sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q4 2021, closing a stake of 19,999 shares — an estimated $81K sold.

Covalis Capital first reported a position in WPCB.WS in Q2 2021 and held it in 2 quarters. The position peaked at $91K in Q2 2021. 53 funds tracked by Wall St. Rank hold WPCB.WS as of Q4 2021.

  • Covalis Capital reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Covalis Capital sold 19,999 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2021, an estimated $81K.
  • Covalis Capital first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 2 quarters.
  • Covalis Capital's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $91K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2021.

Based on Covalis Capital's 13F filing for Q4 2021, filed 14 Feb 2022.